Monte Rosa Therapeutics Inc
Research Monte Rosa Therapeutics Inc (GLUE) on Bullrun: market cap USD 2.02B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGLUE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.02B
- Financial periodFY2025
- RevenueUSD 123.67M
- Revenue growth63.5%
- Net income-USD 38.60M
- Free cash flow-USD 27.50M
Valuation Snapshot
latest market cap is USD 2.02B.
About Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases;
Frequently asked questions
What is Monte Rosa Therapeutics Inc's market cap?
Monte Rosa Therapeutics Inc's market capitalization is USD 2.02B.
What does Monte Rosa Therapeutics Inc do?
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins.